phrykt

SeaStar Medical Holding Corp (ICU): who owns it and who trades it

As of Nov 10, 2026, ICU insiders reported 3 purchases worth $8.5K in the last 12 months. The largest buyer was Michael Messinger (CFO), with $7.5K.

Latest filing Nov 10, 2026. From Form 4, 13F and Schedule 13D/G filings.

At a glance

Insider trades

In the last 12 months, ICU insiders reported $8.5K of open-market purchases and $0 of sales.

Purchases, 12 months
$8.5K
3 trades, 2 people
Sales, 12 months
$0
0 trades, 0 people
Sales under a 10b5-1 plan
–
Share of sale value
Latest trade
Aug 18, 2026
Filed Aug 19, 2026

Purchases and sales by month

$6.1K$6.1KDecFebAprJunAugOct
Purchases Sales Click a bar to show only that month below

Latest trades

DateInsiderRoleTypeSharesPriceValueFiling
Aug 18, 2026Michael MessingerCFOPurchase750$3.27$2.5KForm 4
Dec 19, 2025Jennifer A BairdDirectorPurchase4,200$0.24$1KForm 4
Dec 9, 2025Michael MessingerCFOPurchase14,500$0.35$5.1KForm 4

Insiders by value traded

InsiderRoleBoughtSoldLast trade
Michael MessingerChief Financial Officer$7.5K–Aug 18, 2026
Jennifer A BairdDirector$1K–Dec 19, 2025
What this data shows, and what it doesn't
  • Shows: open-market purchases and sales by officers, directors and 10%+ owners, reported on Form 4 within two business days of the trade.
  • Leaves out: stock awards, option exercises, shares withheld for tax and gifts. These are not trades at a market price chosen by the insider.
  • "plan" marks a sale made under a Rule 10b5-1 plan, a schedule set up in advance.
  • Fund holders come from 13F reports, a snapshot at quarter end filed up to 45 days later.
  • Filings are self-reported and can be amended. Each trade links to its original filing. Methodology

ICU short interest

Low short interest. 4.0% of ICU shares are sold short: about 1 share in 25. Over the last 12 reports the number of shares short went up 13%.

As a rough guide, under 5% is low, 5–10% is moderate, 10–20% is high and over 20% is very high.

0%5%10%15%20%+

As of Oct 30, 2026, 175,168 ICU shares were sold short, 4.0% of the shares outstanding, down 5.7% from the report before. At the average daily volume of 132,096 shares, buying them all back would take about 1.3 trading days (days to cover).

Shares short, % of all shares

3.97%May 15Oct 304.54%

Days to cover

1.3May 15Oct 303.5

Every report

Settlement dateShares short% of sharesChangeAvg daily volumeDays to cover
Oct 30, 2026175,1683.97%-6%132,0961.3
Oct 15, 2026185,8394.22%+29%359,9561.0
Sep 30, 2026143,7243.26%+18%45,4873.2
Sep 15, 2026121,6862.76%+10%44,6282.7
Aug 31, 2026110,6222.51%-9%47,5782.3
Aug 14, 2026121,6872.76%+33%92,0261.3
Jul 31, 202691,1772.28%-34%60,4361.5
Jul 15, 2026138,9253.48%+70%149,7551.0
Jun 30, 202681,9072.05%-37%74,9071.1
Jun 15, 2026129,3103.24%-8%102,1501.3
May 29, 2026141,3153.54%-9%68,4812.1
May 15, 2026154,9073.88%-29%89,1141.7

Short sellers borrow shares and sell them, hoping to buy them back for less. A high number means many such bets are open. It does not say where the price will go. Source: FINRA equity short interest, reported by brokers twice a month (positions on the 15th and the last business day) and published about 7 business days later. % of shares uses the share count on the company's latest SEC filing. What short interest means · Most shorted stocks

SeaStar Medical Holding company events

SeaStar Medical Holding filed 13 reports on Form 8-K in the last 12 months, 4 of them about an important change (leadership). The latest was on Nov 3, 2026.

  1. Nov 3, 2026AnnouncementThe Company issued a press release announcing that the United States Food and Drug Administration has determined that the QUELIMMUNE Pediatric SAVE Surveillance Registry has fulfilled post-approval study requirements as outlined in the original Humanitarian Device Exemption approval of QUELIMMUNE.… Filing
  2. Oct 5, 2026AgreementSeaStar Medical Holding Corporation entered into letter agreements with holders of certain of its issued and outstanding common stock purchase warrants to purchase an aggregate of 854,002 shares of common stock of the Company, par value $0.0001 per share, pursuant to which the Holders exercised… Filing
  3. Aug 12, 2026ResultsReleased financial results. Filing
  4. Jul 1, 2026LeadershipThe Compensation Committee of the Board of Directors of the SeaStar Medical Holding Corporation approved retention bonuses for each of Eric Schlorff and Kevin Chung in the amount set forth below, (a) one-third of which will vest and be payable on July 1, 2026, (b) one-third of which will vest and… Filing
  5. Jun 23, 2026LeadershipAmended an earlier report. Departure of Directors or Certain Officer; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. Filing
  6. Jun 17, 2026LeadershipAs described in Item 5.07 below, on June 17, 2026, the annual meeting of stockholders of SeaStar Medical Holding Corporation was held in order to, among other items, approve an amendment and restatement of the Company’s 2022 Omnibus Incentive Plan to increase the number of authorized shares of… Filing
  7. May 13, 2026ResultsReleased financial results. Filing
  8. Apr 28, 2026AnnouncementForrest A K Wells, a purported stockholder of ours, filed a putative class action complaint in the United States District Court for the District of Colorado, captioned Wells v. Filing
  9. Mar 25, 2026ResultsReleased financial results. Filing
  10. Jan 20, 2026AnnouncementThe Company received a letter from the Nasdaq Office of General Counsel confirming that the Company has regained compliance with the minimum bid price requirement of the Nasdaq Listing Rule 5550(a)(2). Filing
  11. Dec 23, 2025AnnouncementAmended an earlier report. The Company issued a press release announcing that that the Effective Date of the previously stockholder approved Reverse Split will be 12:01 AM January 5, 2026. Filing
  12. Dec 18, 2025SharesChanged the rights of its shareholders. Filing
  13. Nov 17, 2025LeadershipDeparture of Directors or Certain Officer; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. Filing

From 8-K reports, which a company must file within 4 business days of an important event. Where a report is about a change such as a new CEO, the sentence is the first one from the report itself, shortened. Each row links to the original filing. Company events this week

SeaStar Medical Holding financials

5%+ stakes filed in the last 120 days

Anyone who owns more than 5% of a company must report it on Schedule 13D or 13G. 2 filings named ICU in the last 120 days.

FiledHolderFormStake
Nov 10, 2026Mitchell P. Kopin13G/A10.0%
Nov 10, 2026Mitchell P. Kopin13G/A10.0%

Questions about SeaStar Medical Holding Corp (ICU) stock

Are ICU insiders buying or selling?

In the last 12 months, ICU insiders reported 3 open-market purchases worth $8.5K and no sales. The latest trade was on Aug 18, 2026. See every trade.

What is the short interest in ICU?

As of Oct 30, 2026, 175,168 ICU shares were sold short, 4.0% of the shares outstanding, down 5.7% from the report before. At the average daily volume of 132,096 shares, buying them all back would take about 1.3 trading days (days to cover). See the history.

Source: SEC Form 4 (insiders, filed within 2 business days), 13F (funds, up to 45 days after quarter end) and Schedule 13D/13G filings. Only open-market purchases (code P) and sales (code S) are shown. Data only, not investment advice. How we collect it.